Show simple item record

dc.contributor.authorFotopoulos, Georgeen
dc.contributor.authorGoussia, Annaen
dc.contributor.authorBareta, E.en
dc.contributor.authorKoumpis, E.en
dc.contributor.authorChrisafi, S.en
dc.contributor.authorBobos, M.en
dc.contributor.authorMalamou-Mitsi, Vassiliki D.en
dc.contributor.authorFountzilas, Georgeen
dc.contributor.authorPavlidis, Nicholasen
dc.contributor.authorPentheroudakis, Georgeen
dc.creatorFotopoulos, Georgeen
dc.creatorGoussia, Annaen
dc.creatorBareta, E.en
dc.creatorKoumpis, E.en
dc.creatorChrisafi, S.en
dc.creatorBobos, M.en
dc.creatorMalamou-Mitsi, Vassiliki D.en
dc.creatorFountzilas, Georgeen
dc.creatorPavlidis, Nicholasen
dc.creatorPentheroudakis, Georgeen
dc.date.accessioned2018-06-22T09:53:03Z
dc.date.available2018-06-22T09:53:03Z
dc.date.issued2015
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/41633
dc.description.abstractBackground: Cancer of unknown primary (CUP) possesses distinct biology and peculiar natural history, in which the roles of the winged and hedgehog signalling pathways are unclear. Materials and methods: We constructed tissue microarrays and studied the immunohistochemical (IHC) expression of β-catenin, smoothened (SMO) and the transcription factors TCF, LEF, GLI1 in 87 CUP cases for prognostic significance. Results: A low rate of IHC expression of proteins was seen, the cut-off used being any expression in ≥ 1% of tumour cells. At univariate analysis, only nuclear IHC SMO expression displayed a statistically significant association with favourable outcome [median Overall survival (OS) of 19 months in SMO-positive vs. 12 months in SMO-negative cases, P = 0·01]. An activated Wnt pathway, defined as IHC expression of any of nuclear β-catenin, TCF and LEF, was significantly associated with favourable progression free survival (median 9 vs. 5 months, P = 0·037) and OS (median 19 vs. 13 months, P = 0·04). This prognostic impact on OS was mainly driven by nuclear expression of TCF and/or LEF (P = 0·03). No prognostic significance of the hedgehog pathway activation status, defined as IHC expression of SMO or nuclear GLI1, could be established. A favourable prognostic impact of the concurrent activation of both pathways was observed. A trend for association of activated Wnt with response to chemotherapy (responders 67% among activated Wnt cases vs. 35% among nonactivated Wnt cases, P = 0·07) was observed in CUP adenocarcinomas. Conclusions: Activation of the Wnt pathway was a positive prognostic factor in a small CUP series, possibly via enhanced chemosensitivity. Independent validation is warranted. © 2015 Stichting European Society for Clinical Investigation Journal Foundation.en
dc.language.isoengen
dc.sourceEuropean journal of clinical investigationen
dc.subjectCancer chemotherapyen
dc.subjectHumanen
dc.subjectNeoplasmsen
dc.subject80 and overen
dc.subjectAgeden
dc.subjectHumansen
dc.subjectAdulten
dc.subjectAgeden
dc.subjectFemaleen
dc.subjectMajor clinical studyen
dc.subjectCancer survivalen
dc.subjectFollow upen
dc.subjectPriority journalen
dc.subjectPrognosisen
dc.subjectRetrospective studiesen
dc.subjectRetrospective studyen
dc.subjectHuman tissueen
dc.subjectOverall survivalen
dc.subjectCancer prognosisen
dc.subjectCarcinomaen
dc.subjectMaleen
dc.subjectMortalityen
dc.subjectProtein expressionen
dc.subjectImmunohistochemistryen
dc.subjectReceptorsen
dc.subjectSurvival timeen
dc.subjectTreatment responseen
dc.subjectArticleen
dc.subjectMiddle ageden
dc.subjectAdenocarcinomaen
dc.subjectSquamous cellen
dc.subjectSquamous cell carcinomaen
dc.subjectCancer of unknown primary siteen
dc.subjectUnknown primaryen
dc.subjectMetabolismen
dc.subjectNeuroendocrine tumoren
dc.subjectCancer of unknown primaryen
dc.subjectBeta cateninen
dc.subjectCarcinomatous peritonitisen
dc.subjectG protein coupled receptoren
dc.subjectG-protein-coupleden
dc.subjectGli1 proteinen
dc.subjectHedgehogen
dc.subjectHedgehog proteinsen
dc.subjectLymphoid enhancer factor 1en
dc.subjectLymphoid enhancer-binding factor 1en
dc.subjectNeuroendocrine tumorsen
dc.subjectPrognosticen
dc.subjectProgression free survivalen
dc.subjectSmo proteinen
dc.subjectSmoothened proteinen
dc.subjectSonic hedgehog proteinen
dc.subjectSquamous epitheliumen
dc.subjectT cell factor proteinen
dc.subjectTcf transcription factorsen
dc.subjectTissue array analysisen
dc.subjectTissue microarrayen
dc.subjectTranscription factoren
dc.subjectTranscription factor gli1en
dc.subjectTranscription factorsen
dc.subjectVery elderlyen
dc.subjectWinglessen
dc.subjectWnt pathwayen
dc.subjectWnt proteinen
dc.subjectWnt signaling pathwayen
dc.titlePrognostic significance of WNT and hedgehog pathway activation markers in cancer of unknown primaryen
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1111/eci.12518
dc.description.volume45
dc.description.issue11
dc.description.startingpage1145
dc.description.endingpage1152
dc.author.facultyΙατρική Σχολή / Medical School
dc.author.departmentΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen
dc.contributor.orcidPavlidis, Nicholas [0000-0002-2195-9961]
dc.contributor.orcidPentheroudakis, George [0000-0002-6632-2462]
dc.contributor.orcidFotopoulos, George [0000-0001-7393-4080]
dc.gnosis.orcid0000-0002-2195-9961
dc.gnosis.orcid0000-0002-6632-2462
dc.gnosis.orcid0000-0001-7393-4080


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record